Drug Kinetics – News and Features

University of Texas at Dallas researchers and their collaborators are developing a quick-drying polymeric desiccant that could dehumidify buildings using at least 30% less energy than conventional air-conditioning systems.

A new model has been designed to identify drugs that should not be prescribed together. It has already identified common drugs – an antibiotic and a blood thinner – that may interfere with each other.

Columbia Biomedical Engineer Ke Cheng has developed a technique that uses inhalation of exosomes, or nanobubbles, to directly deliver IL-12 mRNA to the lungs of mice.

The theme for LGBT+ History Month this year is Medicine – #UnderTheScope, celebrating the contribution of LGBT+ individuals to medicine and healthcare. Here, we explore key figures often passed over when recounting significant contributions to medicine.

A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds.

In this interview, Dr. Jason Park, co-founder and CEO of Empress Therapeutics, tells us more about the Chemilogics platform and the benefits this approach to drug discovery can offer.

A study has shown that Rucaparib and its main metabolite M324 exhibit differential activities. The paper has analyzed Rucaparib and M324, making a computational prediction of the metabolite’s activity.

An interdisciplinary team of researchers has identified an innovative way to harness the antioxidant and antibacterial properties of the botanical compound lawsone to make nanofiber-coated cotton bandages that fight infection.

After the twists and turns of discovering a drug molecule, pharma companies still face a mighty challenge: delivering their candidate drugs to the area of the body where they are needed.

Purdue researchers have created molecular compounds to inhibit protein aggregation linked with Alzheimer’s disease, Parkinson’s disease and Type 2 diabetes.